The NEXT surgery
A new era in surgery is coming
The future of robotic surgery will be more human, more adaptive and more connected.
We are developing a robotic surgical platform that will set a new standard for the modern OR and transform the surgical experience.
Designing in partnership
Focusing on the biggest challenges of today
Johnson & Johnson MedTech today announced that the company is targeting 2024 U.S. clinical trials for the OTTAVA general surgery robot. The company plans to submit an Investigational Device Exemption application to the Food & Drug Administration (FDA) in 2024 to initiate clinical trials.
The OTTAVA™ Robotic System is under development and is not authorized to be marketed or sold in any market.
Company Group Chairman, Robotics & Digital
Colorectal and General Surgeon, Palm Beach Digital Surgery Institute
- 1 Based on a September 2023 internally conducted survey of 146 surgeons worldwide with experience in robotic surgery.
- 2 Golisch, K. B., Sanders, J. M., Rzhetsky, A., & Tatebe, L. C. (2023). Addressing surgeon burnout through a multi-level approach: A National Call to Action. Current Trauma Reports, 9(2), 28–39.
- 3 The Healthcare Data Explosion Website. https://www.rbccm.com/en/gib/healthcare/episode/the_healthcare_data_explosion. Accessed October 24, 2023.